selective COX-2 inhibitor called Prexige

CLICK HERE to view the Health Canada advisory concerning the removal of Prexige from the Canadian market

  You'll soon see a new selective COX-2 inhibitor called Prexige.

  Health Canada approved it ahead of the U.S. and most other countries. It's for acute and chronic osteoarthritis of the knee.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote